Manuela Spadea: Celebrating Recognition for Pediatric HSCT Research at EHA 2026
Manuela Spadea, Assistant Professor of Pediatrics at University of Turi, shared a post on LinkedIn:
“Grateful that our European Hematology Association (EHA) 2026 poster was selected as one of the top-scoring abstracts and received a travel grant to attend the Congress in Stockholm.
Presenting and discussing our work on early risk stratification after pediatric allogeneic HSCT was a real pleasure.
This is a setting where fever and inflammation can indicate very different clinical paths, ranging from benign febrile neutropenia to infectious or endothelial-driven transplant-related complications.
Importantly, the research is still underway.
We are refining the analyses to enhance statistical power, improve clinical relevance, and better understand how Pro-ADM can aid in risk-based monitoring and decision-making in pediatric HSCT.
A heartfelt thank you to all the co-authors, participating centers, clinical teams, clinical trial office colleagues, patients, and families who made this collaborative effort possible.”
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering